About This Paid Research Study
We are partnering with City of Hope® to look for adults living with Type 1 Diabetes to take part in their
research study to evaluate an experimental personalized immunotherapy (vaccine) for type 1 diabetes. All
study activities will take place at City of Hope® campus in Duarte, California.
The PIpepTolDC vaccine is a type of immunotherapy (a treatment that uses a person’s own immune system). The vaccine is made using your own immune cells and a beta cell protein. The vaccine may help your beta cells recover and make enough insulin to control your blood sugar levels. The vaccine may also help reduce future type 1
You’ll need to complete a risk-free, 20-minute phone call with one of our team members to see if you are
eligible. No health insurance is needed to participate!
You May Qualify If You Are:
- Between 18 and 45 years old
- An adult who has known antibodies or a history of antibodies
- An adult living with type 1 diabetes for 1-4 years
scroll to apply
Sign Up Today
To join this paid research study, you will need to complete an easy and risk-free, 20-minute phone questionnaire about you and your current health status. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling research studies at our research center.
Get To Know Us
ProSciento’s clinical research facility is located 10 miles south of San Diego’s downtown area, 13 miles south of the San Diego International Airport, and 7 miles north of the US/Mexico border.
An on-site parking lot and parking garage are available and located within convenient access to public transportation. Additional transportation options may also be available at no-cost to you.
855 3rd Avenue,
Chula Vista, CA 91911
Monday – Friday
7 a.m. – 6 p.m.